Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pharmacovigilance

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Drug Administration and Therapy Phases: Overview

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

Clinically Relevant Drug Product Specifications: Methods of Establishment

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...

Drug Regulation

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Outcomes and Complications of Pars Plana Vitrectomy for Nonclearing Vitreous Hemorrhage Without Tractional Elements.

Ophthalmology. Retina·2026

Same author

Artificial intelligence and the future of the pharmacist's role in drug information.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2025

Same author

Macular Holes in Tractional Retinal Detachments Secondary to Diabetic Retinopathy.

Journal of vitreoretinal diseases·2024

Same author

Anti-Vascular Endothelial Growth Factor Treatment Patterns and Outcomes in Retinal Vein Occlusion in Routine Clinical Practice.

Ophthalmic surgery, lasers & imaging retina·2022

Same author

Comparison of Student Pharmacists' Knowledge Retention Utilizing Electronic Health Records Versus Simultaneously Completing Simulated Experiences.

American journal of pharmaceutical education·2021

Same author

Implementation and justification of a curriculum-wide electronic health record platform.

Currents in pharmacy teaching & learning·2021

Search research articles

Related Experiment Video

Updated: Jan 5, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Development of a Drug Information Service Collaborative in Academia.

Jeeseon Kim¹, Rebecca Hoover², Scott Perkins³

¹Touro College of Pharmacy New York, NY, USA.

The Annals of Pharmacotherapy

|October 19, 2019

Summary

A new pharmacist-led drug information service bridges the gap between evidence-based medicine (EBM) and clinical practice. This collaborative initiative enhances efficiency and peer learning for healthcare professionals.

Keywords:

clinical pharmacy communication drug information evidence-based medicine evidence-based practice

More Related Videos

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Published on: June 6, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Related Experiment Videos

Last Updated: Jan 5, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Published on: June 6, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Area of Science:

Pharmacy
Clinical Practice
Health Informatics

Background:

Evidence-based medicine (EBM) adoption faces practical barriers in clinical settings.
Gaps persist between EBM principles and routine healthcare delivery.
Existing drug information (DI) services can be improved to support EBM.

Purpose of the Study:

To introduce a pharmacist-led drug information (DI) service initiative.
To address and overcome common barriers hindering EBM practice.
To enhance the integration of EBM into clinical workflows.

Main Methods:

Implementation of a pharmacist-led DI service.
Utilization of technology for service delivery.
Establishment of a collaborative model among academic DI centers.
Pilot testing within a large healthcare system.

Main Results:

Positive user satisfaction reported from the pilot program.
Demonstrated increase in efficiency for DI pharmacists.
Facilitated peer learning and knowledge exchange among pharmacists.
Successful technological collaboration between DI centers.

Conclusions:

The pharmacist-led DI service effectively overcomes EBM practice barriers.
Technological collaboration enhances DI service efficiency and pharmacist development.
The initiative shows promise for improving EBM integration in healthcare.